Preventing Drug Diversion Act of 2018
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (May 14, 2018)
Preventing Drug Diversion Act of 2018
This bill establishes a new requirement intended to help drug manufacturers and distributors identify and prevent suspicious orders of opioids and reduce rates of diversion.
Specifically, the Drug Enforcement Administration must use its automated data system—the Automated Reports and Consolidated Ordering System—to inform drug manufacturers and distributors about the quantity and type of opioids that are distributed to pharmacies and practitioners.
Additionally, the bill establishes new requirements for reporting, collecting, and sharing information about suspicious orders.
What just happenedJun 19, 2018
Placed on Senate Legislative Calendar under General Orders. Calendar No. 471.
Who’s behind it
- Reported to SenateJun 19, 2018
- Introduced in SenateMay 14, 2018
- Jun 19, 2018Calendars
Placed on Senate Legislative Calendar under General Orders. Calendar No. 471.
- Jun 19, 2018Committee
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
Judiciary Committee - Jun 19, 2018Committee14000
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
Judiciary Committee - Jun 14, 2018Committee
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Judiciary Committee - May 14, 2018IntroReferral
Read twice and referred to the Committee on the Judiciary.
Judiciary Committee - May 14, 2018IntroReferral10000
Introduced in Senate